For wheezo to have any chance of success is entirely dependent upon its acceptance by the medical fraternity. Without the “Specialists“ and “Big Pharma” embracing our device - selling it on Amazon or Chemists or GP’s you might as well forget the whole exercise!! Wheezo has to be “sold” from the top down - and not as our old Board wanted to “sell“ from the bottom up! For that reason further important data will be collected by those upcoming trials!! To have any chance to be considered by Big Pharma to partner with us, data and more data is required! By April the trials will be finished - won’t be long after that, discussions will start with various Big Pharma companies! Commercialisation thereafter! This direction by the Board is the only secure way for RSH to show its true potential!!
I speak for quite a few of our Shareholders who have met Marjan and Nick and say again - how lucky we are having you guys!! Your expertise, enthusiasm and drive is amazing!! Respiri is in the best hands possible!
Cheers
RSH Price at posting:
7.8¢ Sentiment: Buy Disclosure: Held
